Get started
Author

Konstantin S. Kochergin-Nikitsky

Observed names: K S Kochergin-Nikitskiĭ, K S Kochergin-Nikitsky, K. Kochergin-Nikitsky, K. S. Kochergin-Nikitskiy, K. S. Kochergin-Nikitsky, K.S. Kochergin-Nikitsky, Kochergin-Nikitsky, Konstantin, Konstantin Kochergin-Nikitsky, Konstantin Kochergin‐Nikitsky, К.С. Кочергин-Никитский, Кочергин-Никитский Константин Сергеевич
Observed institutions: St. Jude Children's Research Hospital, Moscow Institute of Physics and Technology, Gamalei Institute of Epidemiology and Microbiology, D.I. Ivanovsky Institute of Virology Russian Academy of Medical Sciences, Research Centre for Medical Genetics, Abeona Therapeutics (United States)
ORCID: 0000-0002-0096-4542
Observed ORCID: 0000-0002-0096-4542
OpenAlex ID: A5006997639
Epitope Mapping of the Hemagglutinin Molecule of a Highly Pathogenic H5N1 Influenza Virus by Using Monoclonal Antibodies
2007 · Nikolai V. Kaverin, Irina A. Rudneva, et al. · Journal of Virology · 186
Effect of gene constellation and postreassortment amino acid change on the phenotypic features of H5 influenza virus reassortants
2007 · I. A. Rudneva, T. A. Timofeeva, et al. · Archives of Virology · 32
Tissue and cell-type-specific transduction using rAAV vectors in lung diseases
2021 · Konstantin Kochergin-Nikitsky, Lyubava Belova, et al. · Journal of Molecular Medicine · 16
Airway basal cells from human-induced pluripotent stem cells: a new frontier in cystic fibrosis research
2024 · Anna Demchenko, Lyubava Belova, et al. · Frontiers in Cell and Developmental Biology · 14
Antibody-Binding Epitope Differences in the Nucleoprotein of Avian and Mammalian Influenza A Viruses
2011 · Natalia L. Varich, Galina K. Sadykova, et al. · Viral Immunology · 10
Location of antigenic sites recognized by monoclonal antibodies in the influenza A virus nucleoprotein molecule
2009 · Natalia L. Varich, Konstantin S. Kochergin-Nikitsky, et al. · Journal of General Virology · 10
Approaches to purification and concentration of rAAV vectors for gene therapy
2022 · Lyubava Belova, Konstantin Kochergin‐Nikitsky, et al. · BioEssays · 8
Exome, transcriptome and miRNA analysis don’t reveal any molecular markers of TKI efficacy in primary CML patients
2019 · Alexander V. Lavrov, Ekaterina Yu. Chelysheva, et al. · BMC Medical Genomics · 6
PDF
Monitoring of rabies in wild animals in the Kirov region after oral immunization
2016 · O. N. Zaykova, T. V. Grebennikova, et al. · Problems of Virology · 6
Cardiomyopathies associated with the DES gene mutations: molecular pathogenesis and gene therapy approaches
2019 · K. S. Kochergin-Nikitsky, E. V. Zaklyazminskaya, et al. · Almanac of Clinical Medicine · 5
PDF
Methodological landscape in the field of integration site identification of retroviruses and retroviral vectors
2025 · Konstantin Kochergin-Nikitsky, Alexander Lavrov, et al. · Frontiers in Bioengineering and Biotechnology · 4
PDF
Recombinant Adeno-associated Viral Vectors Serotypes 6 and 9 are Able to Transduce Human Tracheal Epithelial Cells but Not Human Induced Pluripotent Stem Cells
2023 · L. Belova, A. Demchenko, et al. · Molecular Biotechnology · 4
Экспериментальные подходы к таргетному редактированию гена CFTR с помощью CRISPR-Cas9
2018 · Лаборатория мутагенеза, Медико-генетический научный центр, Москва, С.А. Смирнихина, et al. · Вестник Российского государственного медицинского университета · 4
PDF
Post-reassortment amino acid change in the hemagglutinin of a human-avian influenza H5N1 reassortant virus alters its antigenic specificity.
2008 · I A Rudneva, T A Timofeeva, et al. · PubMed · 4
Transcriptomic Profile of Directed Differentiation of iPSCs into Hepatocyte-like Cells
2026 · Irina Panchuk, Valeriia Kovalskaia, et al. · International Journal of Molecular Sciences · 3
PDF
Location and architecture of an antibody-binding site of influenza A virus nucleoprotein
2013 · Natalia L. Varich, Galina K. Sadykova, et al. · Archives of Virology · 3
Lung Organoids from hiPSCs Can Be Efficiently Transduced by Recombinant Adeno-Associated Viral and Adenoviral Vectors
2025 · Lyubava Belova, Anna Demchenko, et al. · Biomedicines · 2
Experimental approaches to the target editing of the CFTR gene using CRISPR-Cas9
2018 · S.A. Smirnikhina, A.A. Anuchina, et al. · Bulletin of Russian State Medical University · 2
Stages of research and development of therapeutic approaches for Duchenne myodystrophy. Part II: etiotropic approaches
2024 · K. S. Kochergin-Nikitskiy, S. A. Smirnikhina, et al. · Neuromuscular Diseases · 1
Unexpected extra exon skipping in the DYSF gene during restoring the reading frame by CRISPR/Cas9
2023 · Olga Levchenko, Irina Panchuk, et al. · Biosystems · 1
Genetic markers of stable molecular remission in chronic myeloid leukemia after targeted therapy discontinuation
2018 · Svetlana A. Smirnikhina, Ekaterina Yu. Chelysheva, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1
Chimeric iPSC-Derived Lung Organoids Reveal the Minimum Wild-Type Cell Fraction Detectable by the Forskolin-Induced Swelling Assay in Cystic Fibrosis
2026 · Anna Demchenko, Margarita Lopatina, et al. · International Journal of Molecular Sciences
The evolving landscape of hybrid viral vector architectures: a persisting niche
2026 · Konstantin Kochergin-Nikitsky, Svetlana Smirnikhina · Frontiers in Bioengineering and Biotechnology
PDF
Stages of research and development of therapeutic approaches for Duchenne myodystrophy. Part I: the period before etiotropic approaches introduction
2024 · K. S. Kochergin-Nikitskiy, S. A. Smirnikhina, et al. · Neuromuscular Diseases
PDF
ePS1.01 F508del correction in iPSCs obtained from patient with cystic fibrosis by CRISPR/Cas9
2019 · S. Smirnikhina, A. Anuchina, et al. · Journal of Cystic Fibrosis
PDF
Works count: 36
Citation count: 322
H-index: 7
I10-index: 6
Year
Topic
Type